Skip to content
Hi-Doctor

How to Get CagriSema Online in Split

CagriSema is not yet approved for weight loss in the EU, meaning it's unavailable in Split, Croatia. This article clarifies CagriSema's status and guides you to safe, EU-approved weight-loss treatments accessible online through.

24 April 2026
How to Get CagriSema Online in Split —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

If you're looking to get CagriSema online in Split, Croatia, it's important to understand its current status. CagriSema is an investigational drug that is not yet approved for weight-loss prescription in the European Union. Consequently, Hi-Doctor does not currently offer or prescribe CagriSema. However, there are proven, EU-approved weight-loss medications available today through an online consultation with an EU-licensed doctor. This guide will explain what CagriSema is, why it's not yet a standard option, and how you CAN access safe, effective weight-loss treatments through Hi-Doctor.

What is CagriSema, and why isn't it a normal option yet?

CagriSema is a novel weight-loss medication combining two active components: cagrilintide and semaglutide. Cagrilintide is an amylin analogue, which works by reducing appetite and slowing gastric emptying. Semaglutide is a GLP-1 receptor agonist, known for its effects on appetite regulation and blood sugar control. The combination aims to offer enhanced weight loss compared to either drug alone. Currently, CagriSema is in advanced clinical trials (Phase 3) but has not yet received marketing authorization from the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA). This means it is not legally available for prescription outside of clinical study settings. Attempting to purchase unapproved medications online or from unregulated sources carries significant health risks, including counterfeit products, incorrect dosages, and lack of medical oversight.

Proven weight-loss medications available online today

While CagriSema is not an option, several highly effective and EU-approved medications are available for weight management, prescribed by licensed doctors. These treatments have undergone rigorous testing and are proven to aid significant weight loss when used under medical supervision:

  • Ozempic (semaglutide): Primarily approved for type 2 diabetes, Ozempic also demonstrates significant weight loss and can be prescribed off-label for weight management by an EU-licensed doctor if clinically appropriate.
  • Wegovy (semaglutide): A higher-dose formulation of semaglutide, Wegovy is specifically approved for chronic weight management in eligible patients.
  • Mounjaro (tirzepatide): This dual GIP and GLP-1 receptor agonist is approved for type 2 diabetes and has shown impressive weight loss results, often prescribed for weight management by doctors.
  • Saxenda (liraglutide): An earlier GLP-1 receptor agonist, Saxenda is approved for chronic weight management and is typically administered daily.

How to get a weight-loss prescription online in Split, Croatia

Hi-Doctor makes accessing approved weight-loss medications straightforward and safe for residents in Split and across the EU. Our process ensures you receive care from an EU-licensed professional:

  1. Complete an online questionnaire: Spend 2–3 minutes providing details about your health and medical history.
  2. EU-licensed doctor reviews your case: An experienced doctor assesses your information to determine if a weight-loss medication is suitable and safe for you.
  3. Receive a REMPE prescription: If approved, Hi-Doctor issues a valid REMPE electronic prescription (Spanish standard, valid EU-wide) within 24 hours. This is delivered as a downloadable PDF to your private account and by email.
  4. Pick up at any EU pharmacy: Present your digital or printed prescription at any pharmacy in any EU country, including Croatia, under cross-border prescription directive 2011/24/EU.

The online consultation fee is a flat 25 €. If the doctor determines treatment is not appropriate, this fee is automatically refunded, ensuring no financial risk to you.

Why choose Hi-Doctor over unregulated peptide sellers

Choosing a regulated platform like Hi-Doctor provides crucial safety, legality, and efficacy benefits over unregulated peptide sellers:

  • EU-licensed doctors: Your case is reviewed by qualified medical professionals who can prescribe real, approved medications.
  • Real medications: Prescriptions are for legitimate, pharmacy-grade medications, not 'research chemicals' or unverified substances.
  • Traceability and safety: Medications are sourced from official pharmacies, ensuring quality control and proper storage.
  • Secure and compliant: All interactions occur within your private, RGPD-compliant account, ensuring your data is protected.
  • Proven track record: Hi-Doctor has served over 50,000 patients with a 4.8 Trustpilot rating, reflecting reliable and trusted service.
  • Money-back guarantee: Our 25 € consultation fee is refunded if treatment is not prescribed, offering a risk-free assessment.

Unregulated sellers offer no medical oversight, no guarantee of product authenticity, and pose significant health risks. Hi-Doctor offers a safe, legal, and medically sound path to weight management.

COMMON QUESTIONS

Frequently asked questions

No, CagriSema is not currently approved for prescription or sale in Spain or any EU country. It is still in clinical trials, and purchasing it from unregulated online sources is illegal and dangerous.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.